ReviewJournal of multidisciplinary healthcare2026
From Preconception to Postnatal: Parental Risk Factors for Fetal-Infant Growth Faltering in LMICs-a Scoping Review (2020-2025).
Review in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This review aimed to map the association between parental (both maternal and paternal) risk factors, from preconception through the postnatal period, and fetal-infant growth faltering. Patients and Methods: This scoping review followed the PRISMA-ScR frameworks to systematically gather and analyze evidence from major databases (PubMed, Scopus and Web of Science). The inclusion criteria encompassed studies involving pregnant women, fetuses, or infants aged 0-24 months, including those diagnosed with fetal or infant growth faltering that examined maternal and/or paternal risk factors, conducted in Low- and Middle-Income Countries (LMICs), using study designs such as observational, cross-sectional, cohort, case-control, or randomized controlled trials, and published in English between 2020 and 2025. Data were analysed through thematic synthesis. Results: From 4235 initial records, we identified 17 eligible studies for this review. The findings showed that the determinants of fetal and infant growth disorders are multifaceted, falling into four key areas. These included individual factors including maternal age, education, nutritional status, health condition, reproductive history, mental health and psychological, marital and socioeconomic,occupation, substance use, and infant factors; environmental concerns including household sanitation and hygiene, water, fuel source, house conditions. Community factors including poverty, deprivation, ethnicity, social inequality, and geographical characteristics. Policy factors, including coverage and quality Antenatal care (ANC), and access to maternal and child health services. These factors represent secondary conditions shaped by broader social and structural determinants of health, rather than direct causal factors. The key determinants shown to influence fetal and infant growth are individual, environmental, community, and policy factors. Conclusion: Fetal and infant growth are influenced by a combination of behavioural, socioeconomic, and environmental factors. These factors contribute considerably to the increased risk of growth disorders in fetal and infant.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.